Abstract
The present invention relates to a novel dosage form termed Gummesule, which is a soft edible, chewable capsule that encapsulate an inner gummy fill material for the improvement of bioavailability and enhancement of patient compliance. In particular, said dosage form is a dispersion or dissolution of biolo...